This inventor holds 4 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 2 EPO patents. Top assignee: Zalicus Pharmaceuticals, Ltd.. Active years: 2012-2015.
Location History:
- Vancouver, CA (2012 - 2013)
- Richmond, CA (2015)
Company Filing History:
Years Active: 2012-2015
Title: The Innovative Mind of Jason Tan: A Journey Through Patents and Pharmaceuticals
Introduction
Jason Tan, an accomplished inventor based in Vancouver, CA, has made significant contributions to the field of pharmaceuticals. With a total of four patents to his name, Tan's work focuses primarily on innovative compounds that target calcium channel activity within the body. His research is crucial in developing methods to alleviate various medical conditions caused by unwanted calcium channel activity.
Latest Patents
One of Jason Tan's latest patents involves N-piperidinyl acetamide derivatives as calcium channel blockers. This innovative patent details methods and compounds that effectively ameliorate conditions characterized by undesirable calcium channel activity, particularly unwanted T-type calcium channel activity. The patent includes a series of compounds containing N-piperidinyl acetamide derivatives, which hold the potential to advance treatment options for these conditions significantly.
Career Highlights
Jason Tan is currently employed at Zalicus Pharmaceuticals, Ltd., where he continues to push the boundaries of pharmacological research. His work and dedication have not only earned him multiple patents but also established him as a respected figure in the pharmaceutical industry.
Collaborations
Throughout his career, Tan has collaborated with talented professionals such as Hassan Pajouhesh and Yanbing Ding. These partnerships have allowed for a rich exchange of ideas and innovations, further enhancing the research outcomes and patent developments.
Conclusion
In summary, Jason Tan's journey as an inventor showcases his commitment to advancing medical science through innovative solutions. His work on N-piperidinyl acetamide derivatives is just one example of how his contributions may play a pivotal role in enhancing the quality of treatment for patients facing challenges related to calcium channel activity. With continued efforts at Zalicus Pharmaceuticals, Tan's future in innovation looks promising.